To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

Trial Profile

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2018

At a glance

  • Drugs Prednisolone (Primary) ; Methylprednisolone acetate
  • Indications Rheumatoid arthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors Sun Pharmaceutical Industries
  • Most Recent Events

    • 02 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2019.
    • 02 Feb 2018 Planned primary completion date changed from 1 Aug 2017 to 1 Mar 2019.
    • 21 Apr 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top